Our Publications

Our publications

Preclinical and clinical validation of Eikonizo’s novel HDAC6 PET tracer

Translation of HDAC6 PET Imaging Using [18F]EKZ-001–cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates

[18F]EKZ-001 quantification methods were validated in nonhuman primates (NHP) and used to show that the novel compound EKZ-317 achieves high target occupancy in brain.
Read More

Clinical validation of the
novel HDAC6 radiotracer
[18F]EKZ-001 in the
human brain

[18F]EKZ-001 is safe and appropriate for quantifying HDAC6 expression in the human brain.
Read More
see our latest news
Look some News
female laboratory personnel

June 2, 2020

Under the Microscope: Ludo Van Den Bosch on returning to work, exploring therapeutic strategies to battle ALS & FTD. 

two laboratory personnel

March 10, 2020

Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, Ph.D. of Eikonizo Therapeutics

female laboratory personnel

March 4, 2020

Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer’s And Other Dementia

If you feel something bother you, we are here to help you

Want to learn more?